US2006099589A1PendingUtilityA1

Gene shuffling by template switching

46
Assignee: NUEVOLUTION ASPriority: Jul 23, 2002Filed: Jul 11, 2003Published: May 11, 2006
Est. expiryJul 23, 2022(expired)· nominal 20-yr term from priority
C12P 19/34C12N 15/1096C12N 15/1027C12Q 1/6811
46
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides a new approach to creating novel polynucleotide sequences by point mutation and recombination in vitro of a set of parental sequences. The new polynucleotide sequences can be useful in themselves or they can be used for the templated synthesis of polymers, e.g. polypeptides composed of α-amino acids as occurring naturally in protein synthesis or polymers comprised of β-amino acids or other building blocks as described (Templated molecules).

Claims

exact text as granted — not AI-modified
1 . A method for preparing a template switched product encoded by at least part of one first template and at least part of at least one second template, wherein said product comprises at least one predetermined property, said method comprising the steps of 
 i) providing a first template molecule and at least one second template molecule; and    ii) providing a nucleic acid polymerase; and    iii) synthesising a plurality of different template switched products by contacting sequentially in any order, or simultaneously, at least part of the first template and at least part of the at least one second template with said polymerase under conditions allowing for template dependent nucleotide polymerisation,    wherein the synthesis of each individual template switched product involves at least one template switch,    and wherein the synthesis of the plurality of different template switched products involves a plurality of template switches,    iv) separating at least one template switched product comprising the at least one predetermined property from said plurality of template switched products; and    v) obtaining a template switched product comprising at least one predetermined property    
     
     
         2 . The method of  claim 1 , wherein 
 i) the first template comprises a first activity or encodes a molecule comprising a first activity; and    ii) the second template comprises a second activity or encodes a molecule comprising a second activity; and    iii) the predetermined property of the template switched product is a third activity, either comprised within the template switched product or in a molecule encoded by the template switched product; and    wherein the first and second activities are both different from the third activity.    
     
     
         3 . (canceled)  
     
     
         4 . The method of  claim 1 , wherein the method involves more than two different template switches.  
     
     
         5 - 6 . (canceled)  
     
     
         7 . The method of  claim 1 , wherein the nucleic acid polymerase comprises a RNase H activity.  
     
     
         8 . The method of  claim 1 , wherein said method involves providing in a single reaction mixture more than 10 different templates and obtaining more than 100 different template switched products.  
     
     
         9 . The method of  claim 1 , wherein the polymerase comprises reverse transcriptase activity.  
     
     
         10 - 13 . (canceled)  
     
     
         14 . The method of  claim 1 , wherein the first template and/or the second template are nucleic acid molecules.  
     
     
         15 - 21 . (canceled)  
     
     
         22 . The method of  claim 1 , wherein the first template and/or the second template are RNA molecules.  
     
     
         23 - 25 . (canceled)  
     
     
         26 . The method of  claim 1 , wherein the method furthermore comprises introducing into said first and/or second template one or more template switch signals prior to synthesis of the template switched product.  
     
     
         27 . The method of  claim 26 , wherein the template switch signal is a breakage in the template.  
     
     
         28 . The method of  claim 26 , wherein the template switch signal comprises a predetermined secondary structure.  
     
     
         29 - 32 . (canceled)  
     
     
         33 . The method of  claim 26 , wherein the template switch signal comprises a nucleotide analogue.  
     
     
         34 . The method of  claim 33 , wherein the nucleotide analogue is capable of entering the active site of the polymerase, but not capable of being incorporated into a nucleic acid.  
     
     
         35 . The method of  claim 33 , wherein the nucleotide analogue is capable of being incorporated to the end of a nucleic acid molecule, and wherein incorporation of the nucleotide analogue inhibits elongation of the nucleic acid.  
     
     
         36 . The method of  claim 33 , wherein the nucleotide analogue is a phosphorothioate ribonucleotide analogue.  
     
     
         37 . (canceled)  
     
     
         38 . The method of  claim 27 , wherein the nick(s) are introduced by limited enzymatic digestion.  
     
     
         39 . The method of  claim 38 , wherein the enzymatic digestion is performed by a ribonuclease.  
     
     
         40 . The method of  claim 27 , wherein the breakage is introduced by limited alkaline hydrolysis.  
     
     
         41 . The method of  claim 27 , wherein the breakage is introduced by limited fragmentation using hydroxyl radicals.  
     
     
         42 . The method of  claim 1 , wherein the synthesis comprises addition of one or more factors capable of affecting frequency and/or degree and/or accuracy of template switching.  
     
     
         43 . The method of  claim 42 , wherein said factor is selected from the group consisting of DMS, kethoxal, CMCT, and DEPC.  
     
     
         44 - 52 . (canceled)  
     
     
         53 . The method of  claim 1 , wherein one or more templates have been prepared by a method comprising the steps of 
 i) Providing a DNA molecule; and    ii) Providing a mixture of nucleotides and nucleotide analogues, wherein one or more of said nucleotide analogues once incorporated into a nucleic acid do not allow further elongation; and    iii) Contacting said DNA molecule with said mixture and transcribing and/or replicating said DNA; and    iv) thereby obtaining one or more different templates.    
     
     
         54 . The method of  claim 1 , wherein one or more templates have been prepared by a method comprising the steps of 
 i) providing a RNA molecule; and    ii) fragmenting said RNA molecule into RNA fragments; and    iii) replicating one or more of said RNA fragments; and    iv) thereby obtaining one or more different templates    
     
     
         55 - 56 . (canceled)  
     
     
         57 . The method of  claim 1 , wherein the method comprises amplification of the plurality of template switched products.  
     
     
         58 . The method of  claim 57 , wherein said amplification involves a PCR reaction.  
     
     
         59 . The method of  claim 1 , wherein the sequence of steps are repeated at least once.  
     
     
         60 . The method of  claim 59 , wherein template switched product(s) are used as a first template and/or second template when the method is repeated.  
     
     
         61 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.